siFLUC (sodium)
Product Specifications
UNSPSC Description
siFLUC (sodium) targets firefly luciferase and has no complementarity in mammalian genome. siFLUC (sodium) can be used as the control oligonucleotide control for CEBPA-51.
Target Antigen
Others
Type
Oligonucleotides
Related Pathways
Others
Field of Research
others
Assay Protocol
https://www.medchemexpress.com/sifluc-sodium.html
Purity
94.91
Solubility
10 mM in H2O
Smiles
[siFLUC (sodium)]
Molecular Weight
14452.56
References & Citations
[1]Reebye V, Huang KW, Lin V, et al. Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. Oncogene. 2018;37(24):3216-3228. |[2]Ferreiro I, Genevois C, Konate K, et al. In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery. Pharmaceutics. 2021;13(5):749. |[3]Vaissière A, Aldrian G, Konate K, et al. A retro-inverso cell-penetrating peptide for siRNA delivery. J Nanobiotechnology. 2017;15(1):34.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156865/siFLUC-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156865/siFLUC-sodium-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items